|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, February 14, 2019 ) India Conjugate Vaccine Market:Conjugate vaccine is a type of vaccine that contains bacterial capsular polysaccharide, attached to a protein to enhance immunogenicity and protects against invasive diseases. India is one of the most prominent markets of conjugate vaccines.
Download Free Report Sample (PDF) Here:https://www.researchreporthub.com/report/india-conjugate-vaccine-market/11300/#requestforsample
India is expected to be the fastest growing market due to the government’s focus on research and development in the life sciences domain. By making Pneumococcal Conjugate Vaccine (PCV) available under the Universal immunization program (UIP), the government of India is ensuring equitable access to those who need them the most – the underprivileged and underserved. Hib is one of the leading causes of bacterial meningitis in India and a major cause of childhood pneumonia. The introduction of LPV in India is a significant milestone and a step forward towards accelerating child survival in India, and progress towards achieving national health goals and the Millennium Development Goal 4.
Market Segmentation:
o Based on disease indication, the market is segmented into pneumococcal, haemophilus influenza type b, diphtheria-tetanus-pertussis, meningococcal and others.
o Based on end user, the market is segmented into paediatric and adult.
Key growth factors:
India is projected to be the fastest growing market for conjugate vaccines during the forecast period. Rapidly increasing population, rise in consumer awareness, growing disposable income and healthcare expenditure, modernization of healthcare infrastructure, and a growing medical tourism industry will drive the growth of the Indian market.
....
Get Discount & Customization of this Report Here:https://www.researchreporthub.com/report/india-conjugate-vaccine-market/11300/
Table Of Content
Chapter 1: Executive summary
1.1 Market scope and segmentation
1.2 Key questions answered in this study
1.3 Executive summary - I
1.4 Executive summary - II
Chapter 2: Market overview
2.1. Market definitions
2.2. India market overview – by revenue
- India historical (2015-2017) market revenue (USD Bn)
- India forecasted (2018-2023) market revenue (USD Bn)
2.3. India market overview – by volume
- India historical (2015-2017) market volume (Million units)
- India forecasted (2018-2023) market volume (Million units)
2.4. India market drivers and challenges
2.4.1. India market drivers
2.4.2. India market challenges
2.5. India market trends
2.6. Value chain
Chapter 3: India major segment overview - by disease indication
3.1. Disease indication: Pneumococcal, Hib - by revenue, by volume, CAGR
- Overview - by disease indication
- Market share (2015, 2018 & 2023): Pneumococcal – India (USD Bn, Million units)
- Market share (2015, 2018 & 2023): Hib – India (USD Bn, Million units)
3.2. Disease indication: DTP, Meningococcal - by revenue, by volume, CAGR
- Overview - by disease indication
- Market share (2015, 2018 & 2023): DTP – India (USD Bn, Million units)
- Market share (2015, 2018 & 2023): Meningococcal – India (USD Bn, Million units)
Chapter 4: India major segment overview - by end user
4.1. End-user: Pediatric, Adult - by revenue, by volume, CAGR
- Overview - by end user
- Market share (2015, 2018 & 2023): Paediatric – India (USD Bn, Million units)
- Market share (2015, 2018 & 2023): Adult – India (USD Bn, Million units)
Chapter 5: Competitive landscape
5.1. Company market share
- Top 5 companies
5.2. Company overview - GlaxoSmithKline
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
5.2(A) Executive profile – GlaxoSmithKline
5.3. Company overview – Pfizer Inc.
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
5.3(A) Executive profile - Pfizer Inc.
5.4. Company overview – Merck & Co.
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
5.4(A) Executive profile - Merck & Co.
5.5. Company overview – Novartis
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
.....
Get Complete TOC with Figures and Tables Here:https://www.researchreporthub.com/report/india-conjugate-vaccine-market/11300/#toc
Research Report Hub
Research Report Hub offers wide-ranging collection of market research reports under virtually every market verticals and sub-categories from different publishers across the globe. We offer reliable market intelligence reports and report customization services to better understand current and projected market scenarios. It also gives a clearer depiction of industries and facilitates to simply perceive competitor activity in the respective industry. Our services are also geared towards helping organizations procure market reports at the finest price.
About US
Research Report Hub
Sector 04, Plot 101, Sant Nagar,
Moshi PCNDTA, Pune, 412105
Maharashtra, India
Web:www.researchreporthub.com
Find us on: <||>rnhttps://www.facebook.com/reasearchreporthub/ <||>rnhttps://twitter.com/hub_report <||>rnhttps://www.linkedin.com/company/research-report-hub/
Research Report Hub
Prakriti Mathur
+918448444687
sales@researchreporthub.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
